Novozymes A/S
XMUN:NZM2
Novozymes A/S
XMUN:NZM2
Price:
50.16
EUR
-0.91%
Market Cap:
€13.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
XMUN:NZM2
|
DK |
|
E
|
Exor NV
DUS:EYX
|
NL |
|
Svenska Cellulosa SCA AB
OTC:SCABY
|
SE |
|
U
|
Universal Robina Corp
XPHS:URC
|
PH |
|
C
|
Chemours Co
F:2CU
|
US |
|
A
|
AstraZeneca PLC
OTC:AZNCF
|
UK |
|
Willscot Mobile Mini Holdings Corp
F:WS11
|
US |
|
C
|
China Shenhua Energy Co Ltd
OTC:CSUAY
|
CN |
|
Disc Medicine Inc
NASDAQ:IRON
|
US |
|
F
|
Fresnillo PLC
OTC:FNLPF
|
MX |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
